FR7428M - - Google Patents
Info
- Publication number
- FR7428M FR7428M FR79000485A FR79000485A FR7428M FR 7428 M FR7428 M FR 7428M FR 79000485 A FR79000485 A FR 79000485A FR 79000485 A FR79000485 A FR 79000485A FR 7428 M FR7428 M FR 7428M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR79000485A FR7428M (US08063081-20111122-C00218.png) | 1968-05-06 | 1968-05-06 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR79000485A FR7428M (US08063081-20111122-C00218.png) | 1968-05-06 | 1968-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR7428M true FR7428M (US08063081-20111122-C00218.png) | 1969-11-12 |
Family
ID=9696341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR79000485A Expired FR7428M (US08063081-20111122-C00218.png) | 1968-05-06 | 1968-05-06 |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR7428M (US08063081-20111122-C00218.png) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000026203A1 (en) * | 1998-10-30 | 2000-05-11 | Pharmacia & Upjohn S.P.A. | 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| US7125888B2 (en) | 2002-05-02 | 2006-10-24 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| WO2007006814A1 (en) * | 2005-07-14 | 2007-01-18 | Novo Nordisk A/S | Urea glucokinase activators |
| US7265134B2 (en) | 2001-08-17 | 2007-09-04 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US7598391B2 (en) | 2004-01-06 | 2009-10-06 | Novo Nordisk A/S | Heteroaryl-ureas and their use as glucokinase activators |
| US7897628B2 (en) | 2002-06-27 | 2011-03-01 | Novo Nordisk A/S | Aryl carbonyl derivatives as therapeutic agents |
| US7999114B2 (en) | 2005-07-08 | 2011-08-16 | Novo Nordisk A/S | Dicycloalkylcarbamoyl ureas as glucokinase activators |
| US8318778B2 (en) | 2007-01-11 | 2012-11-27 | Novo Nordisk A/S | Urea glucokinase activators |
| US11833136B2 (en) | 2018-06-12 | 2023-12-05 | Vtv Therapeutics Llc | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs |
-
1968
- 1968-05-06 FR FR79000485A patent/FR7428M/fr not_active Expired
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000026203A1 (en) * | 1998-10-30 | 2000-05-11 | Pharmacia & Upjohn S.P.A. | 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| US7265134B2 (en) | 2001-08-17 | 2007-09-04 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US7125888B2 (en) | 2002-05-02 | 2006-10-24 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US7897628B2 (en) | 2002-06-27 | 2011-03-01 | Novo Nordisk A/S | Aryl carbonyl derivatives as therapeutic agents |
| USRE45183E1 (en) | 2004-01-06 | 2014-10-07 | Novo Nordisk A/S | Heteroaryl-ureas and their use as glucokinase activators |
| US7598391B2 (en) | 2004-01-06 | 2009-10-06 | Novo Nordisk A/S | Heteroaryl-ureas and their use as glucokinase activators |
| US7872139B2 (en) | 2004-01-06 | 2011-01-18 | Novo Nordisk A/S | Heteroaryl-ureas and their use as glucokinase activators |
| US7999114B2 (en) | 2005-07-08 | 2011-08-16 | Novo Nordisk A/S | Dicycloalkylcarbamoyl ureas as glucokinase activators |
| US7884210B2 (en) | 2005-07-14 | 2011-02-08 | Novo Nordisk A/S | Ureido-thiazole glucokinase activators |
| RU2443691C2 (ru) * | 2005-07-14 | 2012-02-27 | Транстех Фарма, Инк. | Мочевинные активаторы глюкокиназы |
| US8586614B2 (en) | 2005-07-14 | 2013-11-19 | Novo Nordisk A/S | Urea glucokinase activators |
| WO2007006814A1 (en) * | 2005-07-14 | 2007-01-18 | Novo Nordisk A/S | Urea glucokinase activators |
| US8318778B2 (en) | 2007-01-11 | 2012-11-27 | Novo Nordisk A/S | Urea glucokinase activators |
| US8362049B2 (en) | 2007-01-11 | 2013-01-29 | Novo Nordisk A/S | Urea glucokinase activators |
| US11833136B2 (en) | 2018-06-12 | 2023-12-05 | Vtv Therapeutics Llc | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |